No Data
No Data
Zai Lab Q1 2024 GAAP EPS $(0.55) Beats $(0.94) Estimate, Sales $87.10M Beat $75.24M Estimate
Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.94) by 41.49 percent. The company reported quarterly sales of $87.10 million whic
BeiGene Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.
BeiGene Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.
BeiGene GAAP EPADS of -$2.41 Beats by $0.48, Revenue of $751.65M Beats by $76.42M
BeiGene Q1 2024 GAAP EPADS $(2.41) Beats $(2.89) Estimate, Sales $751.652M Beat $676.451M Estimate
BeiGene (NASDAQ:BGNE) reported quarterly losses of $(2.41) per share which beat the analyst consensus estimate of $(2.89) by 16.61 percent. This is a 27.84 percent increase over losses of $(3.34) per
信達生物:2023年報
康方生物:2023 年報